ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer.

Charles H Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.